CVS Health’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.7M Hold
60,000
– – 1.09% 21
2026
Q2
$4.96M Hold
60,000
– – 2.2% 15
2026
Q1
$4.96M Buy
+60,000
New +$5.02M 2.34% 12

Other funds holding VCIT

CVS Health's VCIT Position: Q3 2026 in Review

CVS Health held its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) position steady in Q3 2026 at 60,000 shares worth $4.7M. The position accounts for 1.09% of the portfolio, ranked #21.

CVS Health first reported a position in VCIT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.96M in Q1 2026. 1,340 funds tracked by Wall St. Rank hold VCIT as of Q3 2026.

  • CVS Health held 60,000 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $4.7M as of Q3 2026.
  • CVS Health left its Vanguard Intermediate-Term Corporate Bond ETF share count unchanged in Q3 2026.
  • Vanguard Intermediate-Term Corporate Bond ETF made up 1.09% of CVS Health's portfolio in Q3 2026, its #21 holding.
  • CVS Health first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q1 2026 and has held it in 3 quarters since.
  • CVS Health's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $4.96M in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q3 2026.

Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.